Page 8 - Genmark Diagnostics News Today

WILMINGTON, Del., March 15, 2021 (GLOBE NEWSWIRE) -- Rigrodsky Law, P.A. announces that it is investigating GenMark Diagnostics, Inc. ("GenMark") (NASDAQ ...

A healthcare titan is acquiring the diagnostic-test maker for a hefty premium.

Deal confirms reports that GenMark was an acquisition target; company makes tests to detect a range of respiratory ailments such flu strains, COVID-19 strains and others from a single sample

POLITICO Get the Prescription Pulse newsletter Email Sign Up By signing up you agree to receive email newsletters or updates from POLITICO and you agree to our privacy policy and terms of service. You can unsubscribe at any time and you can contact us here. This sign-up form is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply. Presented by Pharmaceutical Care Management Association With Susannah Luthi, Brianna Ehley and Emily Martin On Tap — Biden hikes Medicar...

ZURICH (Reuters) - Roche will buy GenMark Diagnostics, a U.S.-based maker of molecular diagnostic tests in a $1.8 billion deal, the Swiss pharmaceutic...

Roche will buy GenMark Diagnostics, a U.S.-based maker of molecular diagnostic tests in a US$1.8 billion deal, the Swiss pharmaceuticals ...

Roche said it is offering $24.05 a share for GenMark, a premium of some 43 percent to its last quoted share price on February 10.

European stocks ended flat on Monday, with declines led by financial and mining stocks, while gains in betting firm Flutter Entertainment and optimism about a strong economic rebound helped limit losses.

Roche to Buy Covid Test Maker GenMark for $1.8 Billion This content was published on March 15, 2021 - 08:19 March 15, 2021 - 08:19 (Bloomberg) -- Roche Holding AG agreed to buy GenMark Diagnostics Inc. for about $1.8 billion to gain a provider of fast tests for infectious diseases, including Covid-19. The Swiss drugmaker will pay $24.05 a share in cash, it said in a statement Monday. That’s 30% more than Friday’s closing price. The boards of both companies approved the transaction. GenMark�...

Roche Holding AG (SWX: RO) said on Monday that it will buy GenMark Diagnostics (NASDAQ: GNMK) for £1.29 billion. The all-cash deal translates to £17.25 per share. To fully acquire the United States-based molecular diagnostic tests maker, Roche intends to launch a tender offer soon. Roche shares jumped roughly 1% in premarket trading on Monday. […]